Search Results 391-400 of 13739 for monoclonal antibody

  1. Telisotuzumab vedotin-tllv (intravenous route) - Side effects & uses - Mayo Clinic

    Telisotuzumab vedotin-tllv injection is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Staff. December 5, 2020. Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody ...

  3. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  4. Anifrolumab-fnia (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

  5. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  6. Infliximab-axxq (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab-axxq is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

  7. Olaparib And Atezolizumab Either Alone Or In Combination In Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. It is not known whether giving olaparib and ...

  8. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  9. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  10. Atezolizumab With Or Without Cobimetinib In Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery Or Gallbladder Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...